Filing Details
- Accession Number:
- 0001691902-22-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-03 14:46:29
- Reporting Period:
- 2021-12-29
- Accepted Time:
- 2022-01-03 14:46:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1701108 | Spero Therapeutics Inc. | SPRO | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1491371 | Aquilo Capital, L.p. | One Letterman Drive, Suite D4900 Building D, The Presidio San Francisco CA 94129 | No | No | Yes | No | |
1591986 | Aquilo Capital Management, Llc | One Letterman Drive Suite D4900, Building D San Francisco CA 94129 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value | Acquisiton | 2021-12-29 | 75,493 | $14.64 | 4,789,181 | No | 4 | P | Indirect | See footnotes |
Common Stock, $0.001 Par Value | Acquisiton | 2021-12-30 | 50,000 | $15.77 | 4,839,181 | No | 4 | P | Indirect | See Footnotes |
Common Stock, $0.001 Par Value | Acquisiton | 2021-12-31 | 125,000 | $15.75 | 4,964,181 | No | 4 | P | Indirect | See Footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnotes |
No | 4 | P | Indirect | See Footnotes |
No | 4 | P | Indirect | See Footnotes |
Footnotes
- The reporting persons are Aquilo Capital, L.P. (the "Fund"), Aquilo Capital Management, LLC ("Aquilo") and Marc R. Schneidman. Aquilo is the general partner and investment adviser of the Fund and other funds managed by Aquilo that hold securities directly for the benefit of their investors. Aquilo may be deemed to beneficially own such securities indirectly as the investment adviser and general partner of the Fund and affiliated funds, and Mr. Schneidman may be deemed to beneficially own them indirectly as the control person of Aquilo. Each of, Aquilo, the Fund and Mr. Schneidman disclaims beneficial ownership of such securities except to the extent of his or its pecuniary interest therein.
- Aquilo Capital, LP owns only 3,378,881 of the 4,789,181 shares deemed to be beneficially owned by Aquilo Capital Management, LLC. Aquilo Capital, LP did not purchase any of the 75,493 shares purchased in this transaction on 12/29/2021.
- Aquilo Capital, LP owns only 3,378,881 of the 4,839,181 shares deemed to be beneficially owned by Aquilo Capital Management, LLC. Aquilo Capital, LP did not purchase any of the 50,000 shares purchased in this transaction on 12/30/2021.
- Aquilo Capital, LP owns only 3,378,881 of the 4,964,181 shares deemed to be beneficially owned by Aquilo Capital Management, LLC. Aquilo Capital, LP did not purchase any of the 125,000 shares purchased in this transaction on 12/31/2021.